This paper uses a fixed effect model to empirically study the impact of COVID-19 on the innovative ability of listed companies in China. We find that the innovative abilities of Chinese listed companies, both large-scale and small-scale, increase during the pandemic. Moreover, the impact of COVID-19 varies by industry. These results may enhance market confidence and have implications for policy formulation and economic recovery.
No takes yet. Share an insight, caveat, or question.
Han et al. (2020) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: